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ABSTRACT
Mammalian pancreatic β-cells play a pivotal role in
development and glucose homeostasis through the
production and secretion of insulin. Functional failure or
decrease in β-cell number leads to type 2 diabetes (T2D).
Despite the physiological importance of β-cells, the
viability of β-cells is often challenged mainly due to its
poor ability to adapt to their changing microenviron-
ment. One of the factors that negatively affect β-cell
viability is high concentration of free fatty acids (FFAs)
such as palmitate. In this work, we demonstrated that
Yes-associated protein (Yap1) is activated when β-cells
are treated with palmitate. Our loss- and gain-of-function
analyses using rodent insulinoma cell lines revealed
that Yap1 suppresses palmitate-induced apoptosis in
β-cells without regulating their proliferation. We also
found that upon palmitate treatment, re-arrangement of
F-actin mediates Yap1 activation. Palmitate treatment
increases expression of one of the Yap1 target genes,
connective tissue growth factor (CTGF). Our gain-of-
function analysis with CTGF suggests CTGF may be the
downstream factor of Yap1 in the protective mechanism
against FFA-induced apoptosis.
KEYWORDS β-cell, CTGF, F-actin, free fatty acid, Hippo
signaling, Yap1
INTRODUCTION
Pancreatic β-cells synthesize and secrete insulin for glu-
cose homeostasis, and decrease in the number of functional
β-cells results in type 1 and type 2 diabetes. Chronically
increased level of free fatty acids (FFAs) in plasma is linked
to type 2 diabetes (T2D) by causing both insulin resistance
and β-cell failure (Boden and Shulman, 2002; Boden, 2008).
In the pathogenesis of T2D, peripheral organs ﬁrst become
less sensitive to insulin. In order to compensate for this
resistance, β-cells increase the synthesis and secretion of
insulin. This, however, leads to β-cell dysfunction and/or
death and the insulin level become inadequate for a glucose
challenge (Kusminski et al., 2009; Haber et al., 2003; Haber
et al., 2006; Marchetti et al., 2004; Vetere et al., 2014).
Improving the treatment of diabetes has been challenging
due to the limited proliferation of β-cells and their poor ability
of adapting to cytotoxic environments. However, several
therapeutic approaches for diabetes have been taken to
increase or maintain the number of β-cells by inducing pro-
liferation of β-cells, protecting β-cells from cell death and re-
programming other cell types to β-cells (Vetere et al., 2014).
One of the consequences of chronic exposure to the high
level of FFAs is β-cell apoptosis. Among FFAs, saturated
FFAs such as palmitate, one of the most abundant FFAs in
plasma, shows higher toxicity on β-cells than unsaturated
FFAs such as oleate (Eitel et al., 2002; Karaskov et al., 2006;
Maedler et al., 2001). FFAs induce apoptosis in β-cells
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through multiple complex mechanisms. Studies have shown
that FFAs induce oxidative stress such as nitric oxide pro-
duction, leading to mitochondrial DNA (mtDNA) damage and
apoptosis. Ceramide, a fatty acid-containing secondary
messenger, has also been reported to mediate FFA-induced
apoptosis in diabetic rats and primary islets treated with
FFAs (Shimabukuro et al., 1998). Additionally, FFAs reduce
Ca2+ uptake by endoplasmic reticulum (ER) and causes ER
stress followed by the activation of c-Jun N-terminal kinase
(JNK) (Cunha et al., 2008; Eizirik et al., 2008; Karaskov
et al., 2006). FFA receptors such as G protein-coupled
receptor 40 (GPR40), which play an essential role in FFA-
induced insulin secretion under physiological condition,
could also mediate FFA-induced apoptosis (Natalicchio
et al., 2013). Furthermore, signaling pathways that may
transduce apoptotic signals from FFAs have been investi-
gated. JNK and p38 Mitogen-activated protein kinase
(MAPK) pathways become activated upon FFA treatment
and the activation is at least partially controlled by GPR40,
Mitogen-activated protein kinase kinases 4/7 (MKK4/7) and/
or protein kinase A (PKA) (Natalicchio et al., 2013).
Yes-associated protein (Yap1) is a transcriptional co-ac-
tivator which regulates cell proliferation, differentiation and
apoptosis. Yap1 protein has a proline-rich region at its
N-terminus, a TEAD-binding region, one or two WW
domains, an SH3-binding motif, a coiled-coil domain and a
PDZ interaction motif at its C-terminus (Zhao et al., 2010). In
order to execute its function as a transcriptional co-activator,
Yap1 binds to DNA-binding transcription factors, and the
interaction with different DNA-binding factors results in dif-
ferent cellular responses. Identiﬁcation of genes that Yap1
regulates has been growing in number; for instance, bac-
uloviral IAP repeat containing 2/5 (Birc 2/5) inhibit apoptosis,
and connective tissue growth factor (CTGF) and Axl receptor
tyrosine kinase (Axl) promote proliferation (Zhao et al., 2008;
Zhao et al., 2010). In addition to Yap1’s function as an
oncogene, it can induce apoptosis by associating with p73, a
functional homolog of p53, and up-regulate the expression of
pro-apoptotic genes, such as Bcl2-associated X protein
(Bax) and promyelocytic leukemia (PML) (Basu et al., 2003;
Lapi et al., 2008; Zhang et al., 2011).
In the pancreas, Yap1 is one of the factors that determine
the organ size and the composition of different cell types. At
the early stage of pancreatic development, the pancreatic
epithelium is made up of progenitor cells that later differen-
tiate into endocrine, acinar and ductal cells. Yap1 is highly
expressed throughout the pancreas during this stage
(George et al., 2012). Later in the pancreatic development,
the progenitor cells actively proliferate and differentiate into
the three different cell types. Yap1 is now expressed in the
more restricted area of pancreas where ductal- or acinar-
fated cells are present (George et al., 2012). Several lines of
evidence have shown that Yap1 is an essential factor reg-
ulating proliferation and differentiation during this later stage
of pancreatic development (Camargo et al., 2007; Gao et al.,
2013). Conditional overexpression of Yap1 in mice at this
stage interfered with the differentiation program, causing the
increase in the ductal cell population, while reducing the
populations of acinar and endocrine cells (Gao et al., 2013).
Moreover, chimeric mice with the doxycycline-induced
overexpression of Yap1 increased the size of the pancreas
with more acinar cells (Camargo et al., 2007). In the adult
pancreas, Yap1 expression is further limited to ductal and
terminal-duct centroacinar cells with weak expression in
acinar cells and undetectable expression in endocrine cells
(George et al., 2012).
In this study, we explored the role of Yap1 in rodent
insulinoma cell lines. Weak expression of Yap1 was detected
in these insulinoma cell lines. Using loss- and gain-of-func-
tion analyses, we demonstrated that Yap1 is essential for the
maintenance of β-cell viability both under FFA-treated and
untreated conditions. Upon FFA treatment, Yap1 becomes
activated and antagonizes FFA-induced apoptosis. This is
partly done by increasing the expression of CTGF. Factors
like CTGF may go on to play a protective role in promoting
β-cell survival. Such knowledge could be potentially useful
for coming up with therapeutic strategies for treating T2D.
RESULTS
Free fatty acid, palmitate, induces apoptosis
of pancreatic β-cells through F-actin remodeling
Previous studies have shown that saturated free fatty acids
(FFAs) such as palmitate can induce mammalian pancreatic
β-cells to undergo apoptosis (Kusminski et al., 2009). Using rat
INS-1 832/13 cells, we found that palmitate caused cell apop-
tosis in a dosage-dependent manner (Fig. 1A). In this experi-
ment, cells were starved for 12 h before palmitate treatment.
After 24 h of palmitate treatment, cells were harvested and the
population of cells undergoing apoptosis was quantiﬁed
through the Annexin V-based assay (Fig. 1B). Annexin V binds
to phosphatidylserine (PS) presented on the outer leaﬂet of the
plasma membrane of apoptotic and dead cells, whereas pro-
pidium iodide (PI) is a nucleic acid dye which can only stain
dead cells due to the disrupted membrane. Therefore, early
apoptotic cells can be identiﬁed as Annexin V-positive and PI-
negative cells. Oleate, an unsaturated FFA, exhibited a similar
effect on the INS-1 832/13 cells (data not shown).
F-actin arrangement is critical for maintaining β-cell
metabolic function (Kalwat and Thurmond, 2013). To explore
how palmitate induces apoptosis, we tested the involvement
of F-actin by disrupting F-actin polymerization with
Cytochalasin D (CytoD) in INS-1 832/13 cells. We found that
CytoD treatment reduced palmitate-induced apoptosis when
CytoD was applied together with palmitate for 24 h (Fig. 1C).
Another F-actin inhibitor, Latrunculin B (LatB), exhibited a
similar effect (data not shown). This suggests that palmitate
can function through actin cytoskeleton to transduce its
apoptotic signal in β-cells. Interestingly, after a prolonged
treatment (48 h) with CytoD subsequent to palmitate induc-
tion (Fig. 1B, the bottom panel), CytoD was no longer
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effective for this inhibition. Instead, it even enhanced the
palmitate-induced apoptosis (Fig. 1, compare D with C).
Analysis of activated Caspase 3 provided consistent results
(Fig. S1). Thus, F-actin is critical for leading the cells to
palmitate-induced apoptosis; however, once the apoptotic
program is initiated, disruption of actin cytoskeleton does not
arrest the apoptotic event.
Yap1 is activated in palmitate-treated β-cells
One of the genes that are involved in both F-actin remod-
eling and apoptosis in many cell types is Yap1. Yap1 can
serve as an inducer or suppressor of apoptosis by regulating
its target gene expression involved in apoptosis (Basu et al.,
2003; Lapi et al., 2008; Zhao et al., 2008; Zhang et al., 2011).
In addition, Yap1 and F-actin can regulate each other;
accumulation of F-actin activates Yap1, while overexpres-
sion of constitutively active Yap1 increases F-actin level
(Matsui and Lai, 2013; Moroishi et al., 2015). To investigate
the function of Yap1 in mammalian β-cells under a stress
condition, we induced apoptosis by palmitate in INS-1
832/13 cells and monitored the activity of Yap1 at different
stages of apoptosis. Apoptosis began to increase after 10 h
of palmitate treatment and after 24 h, apoptosis increased
signiﬁcantly (Fig. 2A). The activity of Yap1 was demon-
strated by its subcellular localization. After 12 h of palmitate
treatment, Yap1 translocated from cytoplasm to the nucleus.













































































48 h treatment *
Figure 1. Palmitate induces β-cells apoptosis through F-actin remodeling. (A) Apoptosis of rat INS-1 832/13 cells was induced
with palmitate at different concentrations for 24 h. Apoptotic cells were recognized as Annexin V-positive and PI-negative cells and
quantiﬁed through ﬂow cytometry. (B) Time lines along with speciﬁc events for the 24-h and 48-h palmitate treatment procedures.
(C) CytoD reduced palmitate-induced apoptosis under the 24-h treatment as quantiﬁed with the Annexin V assay. (D) CytoD slightly
enhanced palmitate-induced apoptosis under the 48-h treatment. In (C) and (D), ﬁnal concentrations of palmitate (0.3 mmol/L) and
CytoD (0.5 µmol/L) were used, and data show the mean ± SD of four independent experiments. CT: Control; CytoD: Cytochalasin D;
P: Palmitate. Ethanol (solvent of palmitate) and DMSO (solvent of CytoD) were used in the control experiments. “*” and “**” indicate
P < 0.05 and P < 0.01, respectively, by Student’s t-test.
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(Fig. 2C-C′), whereas Yap1 was more localized in cytoplasm
in the untreated cells (Fig. 2B-B′). Yap1 remained in the
nucleus even after 48 h of palmitate treatment (data not
shown). These results indicate that Yap1 is activated after
palmitate-induced apoptosis. This increase in the Yap1
activity upon palmitate treatment was also found in its
phosphorylation level. Western blot analysis demonstrated
that the phosphorylation level of Yap1 at the conserved
Ser127 site decreased after 24 h of palmitate treatment
(Fig. S2A). Similar observations about the subcellular local-
ization of Yap1 were made with mouse MIN6 β-cells
(Fig. 2D-F′), indicating that it might be a general response for
Yap1 to be activated after palmitate-induced apoptosis in
mammalian β-cell lines.
Yap1 promotes β-cell survival under palmitate-treated
conditions
In most studies, Yap1 has been shown to promote cell pro-
liferation and inhibit apoptosis by interacting with transcrip-
tion factors such as TEAD1 (Pan, 2010; Staley and Irvine,
2012; Yu and Guan, 2013). However, in some cell types,
Yap1 appears to promote apoptosis through association with
a transcription factor, p73 (Basu et al., 2003; Lapi et al.,
2008; Zhang et al., 2011). In order to decipher the role of
Yap1 in β-cells, we carried out loss- and gain-of-function
experiments of Yap1 in INS-1 832/13 cells. In the RNA
interference approach, Yap1 knockdown enhanced apopto-
sis of INS-1 832/13 cells even without any treatment
(Fig. 2H). This indicates the requirement of Yap1 in main-
taining the viability of β-cells at normal condition. Using a
phospho-Histone 3 (PH3)-speciﬁc antibody to recognize
Figure 2. Yap1 is translocated to the nucleus upon palmi-
tate treatment to promote β-cell survival. (A) For rat INS-1
832/13 cells, apoptosis began to increase after 10 h of palmitate
(0.3 mmol/L) treatment. Apoptosis was analyzed at indicated
time points via the Annexin V assay. Data show the mean of
three independent experiments. (B-B′, C-C′) Immuno-staining of
the β-cells showed that Yap1 translocated and accumulated in
the nucleus in most cells after 24 h of palmitate treatment. Draq
5 staining was used to identify nuclei in (B′ and C′). Yap1
localization was observed every two hours and Yap1 began to
respond to palmitate treatment after 12 h, later than the initiation
of apoptosis. (D) For mouse MIN6 β-cells, apoptosis was
observed after 48 h of treatment with 0.5 mmol/L palmitate.
Apoptosis was measured with the Annexin V assay. Data show
the mean ± SD of four independent experiments. (E-E′, F-F′) In
MIN6 cells, Yap1 translocated to the nucleus in most cells after
the 48-h palmitate treatment (F-F′), whereas Yap1 was more
evenly distributed in untreated cells (E-E′). Draq 5 is a DNA dye.
(G) Western blot analysis of Yap1 showed the Yap1 shRNA-
mediated knockdown worked effectively to reduce Yap1
expression. (H) Yap1 knockdown promoted apoptosis. Cells
were incubated with Yap1 shRNA-virus for 5 days in this
experiment. (I) Yap1 knockdown did not signiﬁcantly inﬂuence
β-cell proliferation (P > 0.05). The population of PH3-positive
cells was quantiﬁed by ﬂow cytometry after staining with PH3
antibody. (J) Cell counting experiment showed that the increase
of cell number over time was inhibited by the reduction of Yap1.
Cell number was counted on a daily basis for four days.
(K) Yap1 knockdown enhanced apoptosis after the 24-h
palmitate treatment. Yap1 shRNA-virus was incubated with
cells for 2 days in this experiment. (L) Yap1 overexpression
decreased apoptosis with (P < 0.01) or without (P < 0.05) 24-h
palmitate treatment. Lentivirus overexpressing human Yap1
was incubated for 3 days before 12-h serum starvation followed
by the 24-h palmitate treatment. For (G–K), Yap1i: Yap1
shRNA; Ctrl: negative control. Data show the mean ± SD of
four independent experiments. For (L), Yap1: human Yap1
overexpression; Ctrl: empty vector control. Solvents, ethanol
and DMSO alone, were used in the control experiments (CT).
CytoD: Cytochalasin D; P: Palmitate. “*” and “**” indicate


































Figure 3. FFA-induced Yap1 nuclear localization is
dependent on F-actin. Rat INS-1 832/13 cells were
starved in the absence of serum for 12 h followed by the
24-h treatment with palmitate or/and Latrunculin B.
(A) Control with solvents, DMSO and ethanol; (B) Palmitate
(0.3 mmol/L); (C) Latrunculin B (1 µg/mL); (D) Palmitate
(0.3 mmol/L) together with Latrunculin B (1 µg/mL). Yap1
was detected by an anti-Yap1 antibody through immunos-
taining. DAPI stains nucleic acids and served as a nuclear
marker. White arrows show examples of nuclei that
accumulate high levels of Yap1 in (B), or avoid Yap1
nuclear localization in (D).
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mitotic cells, we found that reduction of Yap1 had no signiﬁ-
cant effect on cell proliferation (Fig. 2I). Cell number counting
showed that the rate of increase in cell number became sig-
niﬁcantly low when Yap1 level was reduced (Fig. 2J). Taken
together, the increase in cell number was prevented in the
absence of Yap1 mainly due to increased apoptosis. Impor-
tantly, when Yap1 was knocked down along with palmitate
treatment, the apoptotic cell population increased synergisti-
cally (Fig. 2K). To further test if Yap1 is sufﬁcient to regulate
cell viability, we overexpressed human Yap1 in INS-1 832/13
cells. Yap1 overexpression decreased the population of
apoptotic cells with or without palmitate treatment. We also
observed that the increase in apoptosis upon palmitate
treatment became less signiﬁcant in cells with Yap1 overex-
pression (Fig. 2L). This suggests that Yap1 may provide a
protective function against palmitate-induced apoptosis.
Yap1 activity is regulated by F-actin dynamics
upon palmitate treatment
To test whether Yap1 responds to FFA signaling through
F-actin, F-actin polymerization was blocked by inhibitors
such as CytoD or LatB. INS-1 832/13 cells were exposed to
either palmitate alone or together with the F-actin inhibitors
for 24 h following the 12-h serum starvation. The result
showed that palmitate induced nuclear accumulation of Yap1
(Fig. 3, compare B with A), while LatB treatment alone did
not affect the localization of Yap1 (Fig. 3C). However, when
cells were treated with palmitate along with LatB, the
translocation of Yap1 into the nucleus was partially blocked
(Fig. 3, compare D with B). CytoD exhibited a similar effect
(data not shown). Western blot analysis showed that CytoD
inhibited dephosphorylation of Yap1 at Ser127 induced by
palmitate treatment (Fig. S2A). These results indicate that
F-actin is critically involved in Yap1 activation in responding
to FFA treatment.
Recent studies both in mammalian and Drosophila sys-
tems showed that F-actin dynamics can be regulated by
YAP1 (Yorkie in ﬂies) (reviewed in Matsui and Lai, 2013;
Moroishi et al., 2015). In order to test whether Yap1 regulates
F-actin dynamics and provides feedback in β-cells, Yap 1
was knocked down by RNAi approach and the level of
F-actin was quantiﬁed in INS-1 832/13 cells by ﬂow cytom-
etry. We found that the reduction of Yap1 did not have any
effect on F-actin dynamics (Fig. S2B), and therefore, Yap1
does not appear to use a feedback mechanism to inﬂuence
the dynamics of F-actin in β-cells.
Expression of CTGF is activated by palmitate treatment
in a Yap-dependent manner
Yap1 functions as a transcription co-activator by interacting
with DNA-binding proteins such as TEA-domain proteins
(TEAD) to promote proliferation and inhibit apoptosis (Pan,
2010; Staley and Irvine, 2012; Yu and Guan, 2013). When
associated with p73 transcription factor, Yap1 can promote
apoptosis (Basu et al., 2003; Lapi et al., 2008; Zhang et al.,
2011). We next investigated the expression of which genes
are responsive to Yap1 in mammalian β-cells. INS-1 832/13
cells were treated with palmitate and CytoD separately or in
combination. Expression levels of several Yap1/p73 and
Yap1/TEAD1 target genes were monitored by quantitative
reverse transcription-polymerase chain reaction (RT-PCR). It
turned out that a p73 target gene, Bax, which is a pro-
apoptosis gene, had no obvious change after 24 h of
palmitate treatment; however, its expression was increased
after 48 h. Bax expression was not inﬂuenced by CytoD
(Fig. 4A and 4B). The expression of Pml, which is also an
apoptosis-related gene, was up-regulated under 24-h
palmitate treatment and this up-regulation was dependent on
F-actin (Fig. 4A). However, Pml expression dropped after
48 h (Fig. 4B). Although expression levels of Bax and Pml
were inﬂuenced by palmitate treatment, their expression
patterns were not tightly correlated with Yap1 activity.
Expression of several TEAD1 target genes that include
CTGF, Cyr61 and Axl was also examined. Cyr61 and Axl
expression levels had no signiﬁcant change after palmitate
treatment at either 24-h or 48-h time points (Fig. 4C and 4D).
However, the expression level of CTGF closely followed the
activation pattern of Yap1 upon palmitate treatment. Under
both 24-h and 48-h treatments, CTGF expression was up-
Figure 4. Analysis of Yap1 target gene expression and
effect of CTGF on β-cell viability under palmitate treatment.
Expression of several Yap1 target genes was measured by
quantitative RT-PCR. Rat INS-1 832/13 β-cells were treated
with palmitate and CytoD following either the 24-h or 48-h
treatment procedure, as described in Fig. 1B. (A and B) Yap1/
p73 target genes Bax and Pml showed no correlation with Yap1
activities under palmitate and CytoD treatment. (C and D) Yap1/
Tead1 target gene CTGF showed a consistent expression level
with Yap1 activity regulation by palmitate and CytoD treatment.
(E and F) Yap1 knockdown repressed CTGF overexpression
under palmitate treatment under both 24-h (E) and 48-h
(F) conditions. Data show the mean ± SD of three independent
experiments. For (A–F), solvent, ethanol, was used as control.
CytoD: Cytochalasin D; P: palmitate; Yap1i: Yap1 shRNA; Ctrl:
negative control. (G and H) Human CTGF inhibited palmitate-
induced apoptosis under both the 24-h and 48-h treatments.
Final concentrations of 1 µg/mL of CTGF, 0.3 mmol/L of
palmitate and 0.5 µmol/L of CytoD were used. Under the 48-h
treatment condition, CTGF inhibited apoptosis enhancement
triggered by CytoD. Apoptosis was measured via the Annexin V
assay. Solvents (ethanol, DMSO and NaOAC) were used in the
control experiments. Data showed the mean ± SD of three
independent experiments. (I) Cell counting experiment shows
that CTGF (1 µg/mL) incubation has no obvious effect on the
β-cell number. The number of cells was counted every day for
four days after the treatment of exogenous CTGF. “*” and “**”
indicate P < 0.05 and P < 0.01, respectively, by Student’s t-test.
b
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regulated by palmitate, and this up-regulation was inhibited
by CytoD in both cases (Fig. 4C and 4D). Therefore, the
CTGF expression pattern is consistent with Yap1 activity,
which is activated by palmitate, yet inhibited by CytoD. To
investigate the importance of Yap1 for palmitate-induced
CTGF up-regulation, a loss-of-function experiment was car-
ried out through RNAi approach. When Yap1 level was
reduced, palmitate-induced up-regulation of CTGF expres-
sion was blocked (Fig. 4E and 4F). Interestingly, without the
palmitate treatment, Yap1 knockdown did not inﬂuence the
basal expression level of CTGF (Fig. 4E and 4F). Taken
together, these results support that CTGF is a downstream
target of Yap1 in β-cells under palmitate treatment.
CTGF inhibits FFA-induced apoptosis of β-cells
CTGF is highly expressed in mouse embryonic β-cells and
functions to promote cell proliferation (Gunasekaran et al.,
2012). In adult islets, CTGF expression level is decreased
dramatically, and CTGF no longer promotes cell proliferation
(Gunasekaran et al., 2012). However, high level of CTGF
expression is still detected in adult ducts or the vasculature,
suggesting that CTGF might still be involved in the mainte-
nance of islet function in adult pancreas (Crawford et al.,
2009). Because CTGF turned out to be the best candidate
for a target gene of Yap1 in β-cells, we tested whether CTGF
is able to enhance β-cell viability under palmitate treatment.
INS-1 832/13 cells were treated with palmitate and CytoD by
following the 24-h or 48-h treatment procedures (Fig. 1B),
and human recombinant CTGF was added to the culture
medium together with palmitate. β-Cells were harvested for
apoptotic analysis by ﬂow cytometry after the treatments.
Both 24-h and 48-h palmitate treatments dramatically
increased the apoptotic cell population. Human CTGF par-
tially suppressed the palmitate-induced apoptosis (Fig. 4G
and 4H). Under the 48-h treatment, we observed more
potent anti-apoptotic effect of CTGF; CTGF inhibited apop-
tosis even in the presence of F-actin inhibitor, CytoD (com-
pare Fig. 4H with Fig. 1D). This set of data suggests CTGF
can enhance β-cell survival under palmitate treatment and
act downstream of F-actin modulation.
Although endogenous expression of CTGF has been
reported to be low in adult β-cells, whether β-cells are still
responsive to exogenous CTGF remains unclear. To test
whether CTGF exhibit any effect on β-cell growth, INS-1
832/13 cells were incubated with human CTGF and cell
number was counted over a period of four days. Interestingly,
CTGF incubation did not signiﬁcantly inﬂuence the growth
proﬁle of β-cells (Fig. 4I). Thus, CTGF does not appear to
dramatically affect survival and proliferation of β-cells in the
absence of palmitate-induced apoptosis.
DISCUSSION
Type 2 diabetes is strongly linked to obesity, which is
associated with elevated levels of FFAs in blood. Chronically
elevated FFA promotes insulin resistance and β-cell death
(Morgan and Dhayal, 2009; Prentki and Madiraju, 2011).
Therefore, a better understanding of how FFA signaling
leads to β-cell dysfunction and death would contribute to the
development of strategies for proper management and
treatment of diabetes. In this study, we explored FFA-in-
duced β-cell apoptosis and factors that can increase β-cell
survival against this cytotoxic microenvironment using
rodent insulinoma cell lines.
As Yap1 is critical in regulating cell proliferation and
apoptosis in many mammalian cell types, we investigated
whether the Yap1 activity is required in β-cells. Through
immunoﬂuorescence, we detected the expression of Yap1
protein in rodent insulinoma cell lines, such as INS-1 832/13
and MIN6 (e.g. Fig. 2B and 2E). A previous study has shown
that Yap1 expression was lost following endocrine speciﬁ-
cation in developing mouse embryos and Yap1 was hardly
detected in mouse adult β-cells through immunohistochem-
istry (George et al., 2012). The level of Yap1 protein in
mouse adult islets was relatively lower compared to other
cell types in the pancreas, which may have led to an
underestimate of Yap1 expression in β-cells. Also, it is
possible that gene expression proﬁles differ between primary
β-cells and insulinoma cell lines.
While FFA reduces β-cell viability, we found that Yap1 is
activated in response to FFA treatment as a way for the cells
to minimize the negative impact of FFA on cell survival. We
demonstrated a positive role of Yap1 in maintaining β-cell
viability on the basis of following three lines of evidence.
First, loss-of-function analysis of Yap1 indicated that Yap1
does not signiﬁcantly promote proliferation, but is critical for
suppressing apoptosis of INS-1 832/13 cells (Fig. 2H and 2I).
Absence of Yap1 synergistically increased apoptosis in cells
treated with FFA (Fig. 2K). This protective role of Yap1 was
further supported by the gain-of-function analysis of Yap1.
Increasing the level of Yap1 suppressed apoptosis both
under normal and FFA-treated conditions in INS-1 832/13
cells (Fig. 2L).
Second, upon FFA treatment, Yap1 became dephospho-
rylated and translocated into the nucleus (Figs. 2B, 2C, 2E,
2F and S2A). In many cell types, the activity of Yap1 is
regulated by a tumor-suppressive pathway called the Hippo
(Hpo) signaling pathway. In the Hpo pathway, the activity of
Yap1 gets suppressed when the large tumor suppressor 1/2
(Lats1/2) phosphorylate Yap1 for its cytoplasmic retention
and proteasomal degradation (Zhao et al., 2010). In this
study, we tested whether Lats1 regulates Yap1 activity under
the FFA-mediated stress condition in β-cells. To address this
question, we used the phosphorylation level of Lats1 (at the
conserved Ser909) as a read-out of Lats1 activity. We
showed that Lats1 was dephosphorylated after palmitate
treatment, and this palmitate-induced dephosphorylation
was partially blocked by the disruption of F-actin (Fig. S2C).
This Lats1 activity pattern was consistent with that of Yap1
phosphorylation, supporting a model that Lats1 kinase is
responsible for the phosphorylation of Yap1. In the canonical
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Hpo pathway, the mammalian STE20-like protein kinases
1/2 (Mst1/2) phosphorylate Lats1/2 for regulating their kinase
activity (Zhao et al., 2010). To test whether Mst1/2 is involved
in regulating Lats1/2 activity in β-cells, we monitored the
phosphorylation levels of Mst1 (at Thr183) and Mst2 (at
Thr180). Surprisingly, the phosphorylation level of Mst1/2
increased upon palmitate treatment and co-treatment with
CytoD (Fig. S2D). Activation of Mst1/2 under various stress
conditions, including palmitate, in pancreatic islets and a
β-cell line has been reported (Ardestani et al., 2014). This
suggests the reduction of the phosphorylation level of Lats1
upon palmitate treatment is not due to the inactivation of
Mst1/2. Taken together, although calling for more investiga-
tion, this Yap1’s response may be regulated by its upstream
kinase, Lats1/2, in an Mst1/2-independent manner.
Third, expression of a well-established Yap1 downstream
target gene, CTGF, increased upon FFA treatment and Yap1
is required for this up-regulation in INS-1 832/13 cells
(Fig. 4C–F). Gain-of-function analysis of CTGF exhibited its
protective role against FFA-induced apoptosis (Fig. 4G and
4H). Therefore, we propose a model that Yap1 activation is a
critical step of cellular response to FFA signaling and acti-
vated Yap1 suppresses apoptosis through its downstream
target genes such as CTGF. The CTGF gene was identiﬁed
as a direct YAP/TEAD target required for cell growth (Zhao
et al., 2008). In the mouse embryonic pancreas, CTGF
functions in both endothelial cells and β-cells, and is both
required and sufﬁcient to promote β-cell proliferation (Guney
et al., 2011). However, in adult pancreas, CTGF expression
is lost in β-cells and is only conﬁned to ductal cells and
microvessels with in the islets (Crawford et al., 2009).
Importantly, we found that CTGF expression can be
increased in FFA-treated islets derived from adult mice (data
not shown). Our ﬁnding of exogenous CTGF promoting
β-cell viability under FFA treatment without the induction of
proliferation makes CTGF a good candidate for potential
diabetic treatment.
We also showed that the palmitate-induced apoptosis is
mediated by F-actin dynamics. Our results suggest that
F-actin dynamics plays a key role in activating a protective
mechanism against FFA-induced stress in β-cells. When
F-actin inhibitors were added along with palmitate, the
induction of apoptosis was partially blocked (Fig. 1C). Yap1
activation provides the molecular basis of this protective
mechanism (Figs. 3 and S2). It is intriguing that the disrup-
tion of F-actin polymerization was no longer effective in
suppressing FFA-induced apoptosis if the F-actin inhibitor,
CytoD, was added at a later stage, a day after FFA treat-
ment. Understanding the mechanism of how actin
cytoskeleton regulates the FFA-induced apoptosis needs
more investigation.
FFAs can act through GPR40 to inﬂuence insulin secre-
tion by β-cells (Steneberg et al., 2005). However, whether
GPR40 also mediates FFA-induced apoptosis in β-cells
remains unclear. In mouse NIT-1 β-cells, palmitate-induced
apoptosis was not mediated by GPR40 (Zhang et al., 2007),
while another group found that GPR40 was critical for
palmitate-induced ER stress and apoptosis in mouse MIN6
β-cells (Wu et al., 2012). To explore if palmitate can also act
on GPR40 to induce apoptosis in rat INS-1 cells, we used a
selective GPR40 antagonist, GW1100, to inhibit GRP40
function. The result showed that the loss of GPR40 function
did not prevent palmitate-induced apoptosis; instead,
GW1100 treatment at higher concentrations moderately
enhanced palmitate-induced apoptosis (data not shown).
Although FFA signaling might directly lead to Yap1 acti-
vation, we cannot exclude the possibility that the effect of
FFA on Yap1 activation is indirect. Other signaling pathways,
such as JNK and p38 MAPK pathways, might be deployed
upon FFA treatment to modulate F-actin or other mecha-
nisms to cause Yap1 activation in β-cells (Natalicchio et al.,
2013). Supporting the latter model, Yap1 activation in β-cells
appears to occur after apoptosis has been initiated. In vivo,
apoptotic cells are known to be able to send out proliferative
and survival signals through paracrine as well as autocrine
signaling (e.g. Fan and Bergmann, 2008; Sun and Irvine,
2011). In fact, CTGF is a secretory protein and could be
possibly involved in such a mechanism in vivo.
MATERIALS AND METHODS
Cell culture
Rat INS-1 832/13 and mouse MIN6 β-cells were kindly provided from
Dr. Douglas Cavener’s laboratory, Pennsylvania State University
(Wang et al., 2013). INS-1 832/13 cells were cultured in RPMI 1640
medium (Lonza) with 2.1 mmol/L L-glutamine and 11.1 mmol/L
D-glucose (Lonza) supplemented with 10% FBS (Gemini), 10 mmol/L
HEPES (Lonza), 1 mmol/L NaPyruvate (Thermo Scientiﬁc), and
55 µmol/L β-Mercaptothanol (ME) (Gibco in Invitrogen). MIN6 cells
were cultured in DMEM medium (Invitrogen) with 25 mmol/L D-glu-
cose supplemented with 15% FBS, 10 mmol/L HEPES, and 55 µmol/L
β-ME. The cells were cultured in 37°C with 5% CO2 and medium
was changed every two days. 1:3 dilution was used to pass the cells
when they grow to at least 80% conﬂuence.
Chemical treatment
Palmitate (Sigma) was dissolved in ethanol and was stored as
50 mmol/L solution at −20°C. To assess the effects of FFAs,
palmitate was pre-added to 50 µL culture medium, heated to 70°C
for complete dissolution, and then added the whole 50 µL mixture to
the cells. Cytochalasin D (CytoD) (Sigma) was dissolved in DMSO
(dimethyl sulfoxide) and stored as 2 mmol/L solution at −20°C.
Latrunculin B (LatB) (Millipore) was dissolved in DMSO and stored at
4 mg/mL solution at −20°C. A ﬁnal concentration of 1 µg/mL of
recombinant human CTGF protein (Gemini) was used to treat β-cells
under cultured conditions.
Annexin V staining and ﬂow cytometry
For apoptosis analysis, cells were trypsinized from 24 well plates
and stained using Alex Fluor® 488 Annexin V kit (Invitrogen)
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following manufacturer’s protocol. Flow cytometry data were col-
lected by FC 500 (Beckman Coulter, Inc.).
Overexpression and knockdown of Yap1
Both overexpression and knockdown of Yap1 was done by lentiviral
infection. For knockdown of Yap1, pLKO.1 vector expressing shRNA
of Yap1 (a gift from Dr. Kun-Liang Guan) was transfected together
with pMD2.G and psPAX2 in HEK 293T cells to produce lentiviral
particles. For overexpression of Yap1, pCDH-CMV-MCS-EF1-RFP
vector expressing human Yap1 was transfected together with VSVG
and Pax2 plasmids in HEK 293T cells to produce lentiviral particles
(gifts from Dr. Yingwei Mao). Lentiviral particles were infected into
INS-1 832/13 cells with 8 µg/mL polybrene.
RNA extraction and quantitative reverse transcription polymerase
chain reaction
After chemical treatments of INS-1 832/13 cells, total mRNA was
extracted with RNeasy Mini Kit (Qiagen). Extracted RNA was
reverse transcribed to cDNA with qSciptTM cDNA SuperMix (Quanta)
by following manufacturer’s instructions. Quantitative RT-PCR was
performed using PerfeCTa® SYBR® Green FastMix, RoxTM (Quanta)
and the StepOnePlusTM Real-Time PCR system (Applied Biosys-
tems). Gene expression levels were normalized to Tubulin of the
same sample. Sequences of rat primers used in the experiment are
listed below, Yap1: forward 5′ TCGTTTTGCCATGAACCAGA,
reverse 5′ GGCTGCTTCACTGGAGCACT; Bax: forward 5′ GGA-
TACAGACTCCCCCCGAG, reverse 5′ AACATGTCAGCTGCCA-
CACG; Pml: forward 5′ GCACCATCCCTGAAAAAGAGAC, reverse
5′ TGGCCACATGGTTGTTGTTG; Ctgf: forward 5′ TCTTCGGTGG
GTCCGTGTAC, reverse 5′ TGCAACTGCTTTGGAAGGACT; Cyr61:
forward 5′ ATTGGCAAAGGCAGCTCACT, reverse 5′ AGGTTCCG
TGCCAAAGACAG; Axl: forward 5′ CTGTGATGGAGGGCCAGCT,
reverse 5′ CAGCGACCTTGAGGATGGAG; Tubulin: forward 5′
GAAGTTCGCACTGGCACCTAC, reverse 5′ GATGAGCTGCTCTG
GGTGGA.
Western blot analysis
Western blot was done by running 10% SDS-PAGE, following
standard blotting protocol. Primary antibodies used in this study
include: rabbit anti-cleaved Caspase 3 (1:1000, Cell Signaling),
rabbit anti-YAP (1:1000, Santa Cruz), rabbit anti-Phospho-YAP
(1:500, Cell Signaling), rabbit anti-Lats1 (1:500, Cell Signaling),
rabbit anti-Phospho-Lats1 (1:500, Cell Signaling), rabbit anti-Phos-
pho-Mst1/2 (1:500, Cell Signaling), and mouse anti-α-Tubulin
(1:2000, Sigma) antibodies. Secondary antibodies are donkey anti-
rabbit or mouse IgG antibodies (Amersham).
Immunocytochemistry, ﬂow cytometry and microscopy
For immunocytochemistry, cells were grown on coverslips in 24-well
plates until they became conﬂuent. After chemical treatments, cells
were ﬁxed with 4% PFA, incubated with a primary antibody at room
temperature for 1 h, and then incubated with a secondary antibody in
foil wrap for 1 h at room temperature. For ﬂow cytometry assays,
cells were grown directly on the 24-well plates. After chemical
treatment, cells were trypsinized and harvested before staining.
Antibodies and chemicals used in this study include: anti-YAP
(1:200, Santa Cruz), anti-Phospho-Histone 3 (PH3) (1:100, Cell
signaling), Alexa Fluor 568, Alexa Fluor 594 (1:200, Invitrogen),
Draq 5 (1:400, Cell Signaling), DAPI (4’,6-diamidino-2-phenylindole)
(1:200, Invitrogen), and Phallotoxin (1:200, Invitrogen). Images were
collected by Olympus Fluoview 300 and Olympus Fluoview 1000
confocal laser scanning microscopes. Flow cytometry data were
collected with an FC 500 cytometer (Beckman Coulter, Inc.).
Statistical analysis
Statistical analysis was performed using Student’s t-test on Microsoft
Excel.
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